<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/C90D7E98-8734-42EC-8E32-A325A691A3C3/chart/price-vs-fair-value?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/C90D7E98-8734-42EC-8E32-A325A691A3C3/chart/price-vs-fair-value"/></p>
<p>納斯達克：REAL 1 年股價與公允價值</p>
<p>探索來自社區的 RealReal 公允價值並選擇您的觀點</p>
<p><strong>The RealReal, Inc.</strong>（納斯達克：REAL）剛剛發佈了最新的季度業績，情況看起來樂觀。收入和每股虧損均好於預期，收入為 1.65 億美元，比預期高出 3.5%。法定虧損小於分析師預期，每股虧損為 0.10 美元。分析師通常在每次財報發佈時更新他們的預測，我們可以從他們的估計中判斷他們對公司的看法是否發生了變化，或者是否有新的關注點。讀者會高興地知道，我們匯總了最新的法定預測，以查看分析師在最新業績發佈後是否改變了對 RealReal 的看法。</p>
<p>人工智能即將改變醫療保健。這 20 只股票正在從早期診斷到藥物發現等各個方面進行工作。最棒的是——它們的市值都在 100 億美元以下——現在仍然有機會提前入場。</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/159488957-earnings-and-revenue-growth-1-dark-2/1754836080150?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/159488957-earnings-and-revenue-growth-1-dark-2/1754836080150"/></p>
<p>納斯達克：REAL 收入和收益增長 2025 年 8 月 10 日</p>
<p>考慮到最新的業績，RealReal 的八位分析師目前的共識是 2025 年的收入為 6.726 億美元。這將反映出過去 12 個月收入的 5.6% 的適度增長。RealReal 也預計將實現盈利，法定每股收益為 0.26 美元。在這份最新報告之前，市場共識預期收入為 6.579 億美元，每股虧損為 0.12 美元。因此，我們可以看到，在最新業績發佈後，預期有了明顯的上調，預計適度的收入增長將使盈利提前於之前的預測。</p>
<p>查看我們對 RealReal 的最新分析</p>
<p>儘管分析師上調了他們的收益預期，但共識價格目標仍保持在 8.91 美元，這表明預測的表現對公司估值沒有長期影響。不過，還有另一種看待價格目標的方法，那就是查看分析師提出的價格目標範圍，因為廣泛的估計範圍可能表明對業務可能結果的不同看法。目前，最樂觀的分析師將 RealReal 的每股價值定為 15.00 美元，而最悲觀的分析師則定為 2.40 美元。正如您所看到的，估計範圍很廣，最低估值不到最樂觀估計的一半，這表明分析師對該業務的表現有着強烈的分歧。因此，基於共識價格目標做出決策可能不是一個好主意，畢竟這只是這一廣泛估計範圍的平均值。</p>
<p>現在從更大的視角來看，我們可以通過將這些預測與過去的表現和行業增長預期進行比較來理解這些預測。根據分析師的説法，到 2025 年底的這一時期將保持相似的趨勢，預計收入將以 12% 的年化速度增長。這與過去五年的 13% 的年增長率相符。與更廣泛的行業相比，分析師的估計（總體）表明，行業收入年增長率為 5.7%。因此，儘管預計 RealReal 將保持其收入增長率，但其增長速度顯然將快於更廣泛的行業。</p>
<h2>結論</h2>
<p>最重要的是要認識到，分析師對該業務前景的信心發生了明顯的變化，預計 RealReal 將在明年實現盈利。令人欣慰的是，他們還上調了收入預期，並預計其增長速度將快於更廣泛的行業。共識價格目標保持在 8.91 美元，最新的估計不足以對其價格目標產生影響。</p>
<p>考慮到這一點，我們不應過於急於對 RealReal 得出結論。長期的盈利能力遠比明年的利潤重要。在 Simply Wall St，我們有一系列到 2027 年的 RealReal 分析師估計，您可以在我們的平台上免費查看。</p>
<p>此外，您還應該瞭解我們發現的關於 RealReal 的 <strong>一個警告信號</strong>。</p>

REAL

<p>分析師在 The RealReal, Inc.（納斯達克代碼：REAL）最近公佈季度業績後更新了他們的預估，該業績顯示出超出預期的收入為 1.65 億美元，且每股虧損小於預期，為 0.10 美元。2025 年的共識預測現在預計收入為 6.726 億美元，每股收益為 0.26 美元，表明盈利能力的轉變。儘管進行了上調，但共識目標價仍保持不變，為 8.91 美元，反映出分析師的預估範圍廣泛，從 2.40 美元到 15.00 美元不等。總體而言，分析師預計 RealReal 的增長速度將快於更廣泛的行業，預計年收入增長為 12%</p>

<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/C90D7E98-8734-42EC-8E32-A325A691A3C3/chart/price-vs-fair-value" alt="" original-src="https://images.simplywall.st/company/C90D7E98-8734-42EC-8E32-A325A691A3C3/chart/price-vs-fair-value"/></p>
<p>NasdaqGS:REAL 1 Year Share Price vs Fair Value</p>
<div class="lb-trans"><p>納斯達克：REAL 1 年股價與公允價值</p>
</div><p>Explore RealReal's Fair Values from the Community and select yours</p>
<div class="lb-trans"><p>探索來自社區的 RealReal 公允價值並選擇您的觀點</p>
</div><p><strong>The RealReal, Inc.</strong> (NASDAQ:REAL) just released its latest quarterly results and things are looking bullish. Revenues and losses per share were both better than expected, with revenues of US$165m leading estimates by 3.5%. Statutory losses were smaller than the analystsexpected, coming in at US$0.10 per share. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. Readers will be glad to know we've aggregated the latest statutory forecasts to see whether the analysts have changed their mind on RealReal after the latest results.</p>
<div class="lb-trans"><p><strong>The RealReal, Inc.</strong>（納斯達克：REAL）剛剛發佈了最新的季度業績，情況看起來樂觀。收入和每股虧損均好於預期，收入為 1.65 億美元，比預期高出 3.5%。法定虧損小於分析師預期，每股虧損為 0.10 美元。分析師通常在每次財報發佈時更新他們的預測，我們可以從他們的估計中判斷他們對公司的看法是否發生了變化，或者是否有新的關注點。讀者會高興地知道，我們匯總了最新的法定預測，以查看分析師在最新業績發佈後是否改變了對 RealReal 的看法。</p>
</div><p>AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.</p>
<div class="lb-trans"><p>人工智能即將改變醫療保健。這 20 只股票正在從早期診斷到藥物發現等各個方面進行工作。最棒的是——它們的市值都在 100 億美元以下——現在仍然有機會提前入場。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/159488957-earnings-and-revenue-growth-1-dark-2/1754836080150" alt="" original-src="https://images.simplywall.st/asset/chart/159488957-earnings-and-revenue-growth-1-dark-2/1754836080150"/></p>
<p>NasdaqGS:REAL Earnings and Revenue Growth August 10th 2025</p>
<div class="lb-trans"><p>納斯達克：REAL 收入和收益增長 2025 年 8 月 10 日</p>
</div><p>Taking into account the latest results, the current consensus from RealReal's eight analysts is for revenues of US$672.6m in 2025. This would reflect an okay 5.6% increase on its revenue over the past 12 months. RealReal is also expected to turn profitable, with statutory earnings of US$0.26 per share. Before this latest report, the consensus had been expecting revenues of US$657.9m and US$0.12 per share in losses. So we can see there's been a pretty clear upgrade to expectations following the latest results, with a modest lift to revenues expected to lead to profitability earlier than previously forecast.</p>
<div class="lb-trans"><p>考慮到最新的業績，RealReal 的八位分析師目前的共識是 2025 年的收入為 6.726 億美元。這將反映出過去 12 個月收入的 5.6% 的適度增長。RealReal 也預計將實現盈利，法定每股收益為 0.26 美元。在這份最新報告之前，市場共識預期收入為 6.579 億美元，每股虧損為 0.12 美元。因此，我們可以看到，在最新業績發佈後，預期有了明顯的上調，預計適度的收入增長將使盈利提前於之前的預測。</p>
</div><p>View our latest analysis for RealReal</p>
<div class="lb-trans"><p>查看我們對 RealReal 的最新分析</p>
</div><p>Althoughthe analysts have upgraded their earnings estimates, there was no change to the consensus price target of US$8.91, suggesting that the forecast performance does not have a long term impact on the company's valuation. There's another way to think about price targets though, and that's to look at the range of price targets put forward by analysts, because a wide range of estimates could suggest a diverse view on possible outcomes for the business. Currently, the most bullish analyst values RealReal at US$15.00 per share, while the most bearish prices it at US$2.40. As you can see the range of estimates is wide, with the lowest valuation coming in at less than half the most bullish estimate, suggesting there are some strongly diverging views on how analysts think this business will perform. As a result it might not be a great idea to make decisions based on the consensus price target, which is after all just an average of this wide range of estimates.</p>
<div class="lb-trans"><p>儘管分析師上調了他們的收益預期，但共識價格目標仍保持在 8.91 美元，這表明預測的表現對公司估值沒有長期影響。不過，還有另一種看待價格目標的方法，那就是查看分析師提出的價格目標範圍，因為廣泛的估計範圍可能表明對業務可能結果的不同看法。目前，最樂觀的分析師將 RealReal 的每股價值定為 15.00 美元，而最悲觀的分析師則定為 2.40 美元。正如您所看到的，估計範圍很廣，最低估值不到最樂觀估計的一半，這表明分析師對該業務的表現有着強烈的分歧。因此，基於共識價格目標做出決策可能不是一個好主意，畢竟這只是這一廣泛估計範圍的平均值。</p>
</div><p>Taking a look at the bigger picture now, one of the ways we can understand these forecasts is to see how they compare to both past performance and industry growth estimates. The period to the end of 2025 brings more of the same, according to the analysts, with revenue forecast to display 12% growth on an annualised basis. That is in line with its 13% annual growth over the past five years. Compare this with the broader industry, which analyst estimates (in aggregate) suggest will see revenues grow 5.7% annually. So although RealReal is expected to maintain its revenue growth rate, it's definitely expected to grow faster than the wider industry.</p>
<div class="lb-trans"><p>現在從更大的視角來看，我們可以通過將這些預測與過去的表現和行業增長預期進行比較來理解這些預測。根據分析師的説法，到 2025 年底的這一時期將保持相似的趨勢，預計收入將以 12% 的年化速度增長。這與過去五年的 13% 的年增長率相符。與更廣泛的行業相比，分析師的估計（總體）表明，行業收入年增長率為 5.7%。因此，儘管預計 RealReal 將保持其收入增長率，但其增長速度顯然將快於更廣泛的行業。</p>
</div><h2>The Bottom Line</h2>
<div class="lb-trans"><h2>結論</h2>
</div><p>The most important thing to take away is that there's been a clear step-change in belief around the business' prospects, with the analysts now expecting RealReal to become profitable next year. Happily, they also upgraded their revenue estimates, and are forecasting them to grow faster than the wider industry. The consensus price target held steady at US$8.91, with the latest estimates not enough to have an impact on their price targets.</p>
<div class="lb-trans"><p>最重要的是要認識到，分析師對該業務前景的信心發生了明顯的變化，預計 RealReal 將在明年實現盈利。令人欣慰的是，他們還上調了收入預期，並預計其增長速度將快於更廣泛的行業。共識價格目標保持在 8.91 美元，最新的估計不足以對其價格目標產生影響。</p>
</div><p>With that in mind, we wouldn't be too quick to come to a conclusion on RealReal. Long-term earnings power is much more important than next year's profits. At Simply Wall St, we have a full range of analyst estimates for RealReal going out to 2027, and you can see them free on our platform here..</p>
<div class="lb-trans"><p>考慮到這一點，我們不應過於急於對 RealReal 得出結論。長期的盈利能力遠比明年的利潤重要。在 Simply Wall St，我們有一系列到 2027 年的 RealReal 分析師估計，您可以在我們的平台上免費查看。</p>
</div><p>Plus, you should also learn about the <strong>1 warning sign</strong> we've spotted with RealReal .</p>
<div class="lb-trans"><p>此外，您還應該瞭解我們發現的關於 RealReal 的 <strong>一個警告信號</strong>。</p>
</div>

分析師在 The RealReal, Inc.（納斯達克股票代碼：REAL）公佈第二季度業績後更新了他們的預測